In the News
Preparing for data transparency requirements of the new EU CTR
The authors discuss some steps organizations must take now to ensure readiness for the application of the EU Clinical Trial Regulation.
Development strategies for cell and gene therapy methods
The authors discuss how the increase in regulatory filings for cell and gene therapies requires reevaluation of bioassay methods because of their complexity.
CRO industry update
PPD’s Les Enterline explains that COVID-19 has accelerated the need for clients to have rapid access to additional highly trained professionals to support their pipelines in what already was a highly competitive market.
PPD cuts the ribbon on new clinical research lab in Suzhou, China
PPD held a grand opening ceremony for its new multipurpose laboratory in Suzhou, China, to support Western and China-based pharmaceutical and biotech companies managing China research studies.
PPD opens clinical research lab in Suzhou, China
The 67,000-square-foot facility offers bioanalytical, biomarker and vaccine laboratory services to support trials across all phases of pharmaceutical development.
PPD adds cell and gene therapy testing capabilities to Irish site
PPD is expanding its Athlone, Ireland, GMP (good manufacturing practices) laboratory, significantly increasing the size of its current facility and adding cell and gene therapy testing.
PPD sees major sales jump for its last financial update, as Thermo Fisher begins buyout
PPD reports its first quarter 2021 financial results.
PPD doubles down on Science 37 collab for siteless trial push
PPD and Science 37 announced an innovative collaboration in which PPD will be fully enabled to design, build, test, implement and execute digital trials using Science 37's DCT platform.
Optimizing clinical trial decision-making
Ravi Ramachandran discusses the need for technologies that accommodate trial participants to obtain a more holistic view of their condition during the clinical research process.
